Literature DB >> 24634876

Ocular findings in children with thalassemia major in Eastern Mediterranean.

Adnan Aksoy1, Murat Aslankurt1, Lokman Aslan1, Ozlem Gül2, Mesut Garipardıç2, Oğuz Celik3, Seydi Okumuş3, Murat Ozdemir1, Gökhan Ozdemir1.   

Abstract

AIM: To investigate ophthalmologic findings in children with thalassemia major (TM) and compare the findings with healthy controls.
METHODS: In a cross-sectional study, 43 children with thalassemia major from pediatric hematology outpatient clinics from two university hospitals and age/sex matched 47 healthy children were included in the study. After a complete ophthalmic examination, tear function tests including the Schirmer test, fluorescein tear break-up time (BUT), ultrasound pachymetry, and axial length measurement were performed. Obtained data was recorded for statistical analysis and the values of right eyes were compared between groups.
RESULTS: The mean best corrected visual acuity was 1.34±0.75 in TM and 1.08±0.28 in controls. It was found lower than 0.1 logMAR unit in 10 (23.2%) children with TM and 2 (4.2%) in controls, and the difference was statistically significant (P<0.05). The mean central corneal thickness was 540±26.95 in children with TM and 536.98±20.45µm in controls (P>0.05). The mean axial length was 22.53±0.50 in TM and 22.57±0.43mm in the control group. The mean Schirmer test score was 19.94±6.91 in TM and 24.22±3.95mm in the control group (P<0.01). The mean BUT score was 9.62±1.28 in TM and 9.73±0.6s in the control group (P>0.05).
CONCLUSION: In TM, while corneal thickness, axial length, and BUT are close to controls, the Schirmer scores are less than normal. The study revealed that TM may be affected by the tear function and visual acuity.

Entities:  

Keywords:  axial length; central corneal thickness; ocular findings; tear function test; thalassemia major

Year:  2014        PMID: 24634876      PMCID: PMC3949471          DOI: 10.3980/j.issn.2222-3959.2014.01.22

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

Review 1.  Beta-thalassemia.

Authors:  Deborah Rund; Eliezer Rachmilewitz
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

2.  Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption.

Authors:  Morteza Mehdizadeh; Mohammad Hosein Nowroozzadeh
Journal:  Clin Exp Optom       Date:  2009-06-10       Impact factor: 2.742

3.  Ocular findings among thalassemia patients.

Authors:  Ali Taher; Ziad Bashshur; Wael A Shamseddeen; Raja-Elie E Abdulnour; Elie Aoun; Suzann Koussa; Patrick Baz
Journal:  Am J Ophthalmol       Date:  2006-10       Impact factor: 5.258

4.  Ocular refractive and biometric characteristics in patients with thalassaemia major.

Authors:  Mohammad Hosein Nowroozzadeh; Zahra Kalantari; Khadije Namvar; Mohammad Hassan Meshkibaf
Journal:  Clin Exp Optom       Date:  2011-02-16       Impact factor: 2.742

5.  Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: our experience.

Authors:  Jitendra Jethani; Kenshuk Marwah; Shashank Patel; Bela Shah
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

6.  Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy.

Authors:  V Lakhanpal; S S Schocket; R Jiji
Journal:  Ophthalmology       Date:  1984-05       Impact factor: 12.079

7.  [Ocular function in beta-thalassemia patients].

Authors:  M Iu Sultanov; N M Gadzhieva
Journal:  Vestn Oftalmol       Date:  1992 Jul-Dec

Review 8.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

9.  Ocular findings in beta-thalassemia.

Authors:  R Sorcinelli; A Sitzia; A Figus; M E Lai
Journal:  Metab Pediatr Syst Ophthalmol (1985)       Date:  1990

Review 10.  Beta-thalassemia.

Authors:  Antonio Cao; Renzo Galanello
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

View more
  4 in total

Review 1.  β-Thalassemia and ocular implications: a systematic review.

Authors:  Aliki Liaska; Petros Petrou; Constantinos D Georgakopoulos; Ramza Diamanti; Dimitris Papaconstantinou; Menelaos G Kanakis; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

2.  Anterior Chamber Angle, Intraocular Pressure, and Globe Biometric Parameters in the Children with β-Thalassemia Major.

Authors:  Nermien Sm El-Haddad
Journal:  J Curr Glaucoma Pract       Date:  2020 Jan-Apr

3.  Evaluation of Corneal Epithelial Thickness and Dry Eye Disease Tests in Thalassemic Adolescents.

Authors:  Weam Mohamed Ebeid; Mahmoud Adel Kenny; Tamer AbdelFattah Badran
Journal:  Clin Ophthalmol       Date:  2021-04-06

4.  Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran.

Authors:  Sezaneh Haghpanah; Omid Reza Zekavat; Mohammadreza Bordbar; Mehran Karimi; Soheila Zareifar; Sanaz Safaei; Mani Ramzi; Hossein Ashraf
Journal:  BMC Ophthalmol       Date:  2020-09-22       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.